S
Sutro Biopharma, Inc. (STRO)
NGM – Real Time Price. Currency in USD
30.52
+0.97 (3.28%)
At close: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
After-hours: Jun 26, 2026, 6:06 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
30.52
+0.97 (3.28%)
At close: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
After-hours: Jun 26, 2026, 6:06 PM EDT
No Data
There are no news for this stock.
Total debt $242.7M significantly exceeds cash reserves ($73.7M), raising financial stability concerns
Total current assets $221.0M exceed Total current liabilities $70.8M, highlighting excellent liquidity
Debt-to-equity ratio (-3.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-3.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$42.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.12 | 6.05 | 10 | |
| Quick ratio | 3.12 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 1.00 | 1.04 | 2.0 | |
| Interest coverage | -3.13 | -16.91 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 68M | 154M | 62M | 102M | 100M |
| Gross Profit | 59M | 147M | 55M | 95M | 93M |
| Operating Income | -129M | -89M | -238M | -105M | -87M |
| Net Income | -119M | -107M | -227M | -191M | -154M |
| EBITDA | -121M | -82M | -231M | -98M | -80M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -81.83 | -56.95 | 1.0 |
| Next quarter | 7.25 | 69.6 | 7.5 |
| Current year | -56.03 | 61.19 | 5.5 |
| Next year | -22.54 | 14.17 | 4.5 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 24.69 | 17.7 | 44.42 | -58.79 | 7.5 |
| Y/Y | -16.52 | 49.34 | 67.69 | 38.79 | 7.8 |
| 3y average | 44.13 | -28.85 | -5.99 | -883.4 | 3.3 |
| 5y average | 37.35 | -65.59 | -30.37 | -516.82 | 3.3 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |